Enfermedad nodular tiroidea. Diagnóstico y tratamiento

Medicina Clinica

Volumn 114, Issue 5, 2000, Pages 181-184

  Martín, Anna M Lucas ^a   Pedrol, Núria Alonso ^a   Sala, Anna Sanmartí ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DECISION TREE; FEMALE; HUMAN; MALE; THYROID NODULE; ANEURYSM; ECHOGRAPHY; GRAVES DISEASE; LYMPHOMA; NODULAR GOITER; PARATHYROID ADENOMA; SHORT SURVEY; SYMPTOM; THYROID ADENOMA; THYROID CARCINOMA; THYROID SCINTISCANNING; THYROIDECTOMY; THYROIDITIS;

DECISION TREES; FEMALE; HUMANS; MALE; THYROID NODULE;

ANTITHYROID AGENT; CALCITONIN; LEVOTHYROXINE; RADIOACTIVE IODINE; THYROXINE;

EID: 0043231533     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(00)71236-x     Document Type: Article

References (47)

1. Gharib H. Changing concepts in the diagnosis and management of thyroid nodules. Endocrinol Metab Clin North Am 1997; 26: 777-800.
2. Hermus AR, Huysmans DA. Treatment of benign nodular thyroid disease. N Engl J Med 1998; 338: 1438-1447.
3. Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997; 126: 226-231.
4. Gharib H, Mazzafern EL. Thyroxine suppressive therapy in patients with nodular thyroid disease. Ann Intern Med 1998; 128: 386-394.
5. 1 ed.). Nueva York: Churchill Livingstone, 1996; 189-254.
6. 1 ed.). Londres: Prentice-Hall International Inc., 1997; 192-262.
7. Burch HB, Evaluation and management of the solid thyroid nodule. Endocrinol Metab Clin North Am 1995 24: 633-710.
8. Gharib H. Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect. Mayo Clin Proc 1994; 69: 44-49.
9. Blumm M. Why do the clinicians continue to debate the use of levothyroxine in the diagnosis and management of thyroid nodules? Ann Intern Med 1995; 122: 63-64.
10. Daniels GH. Thyroid nodules and nodular thyroids: a clinical overview. Compr Ther 1996; 22: 239-250.
11. Cooper DS. Tnyroxine suppression therapy for benign nodular d sease. J Clin Endocrinol Metab 1995; 80: 331-334.
12. Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 1993; 118: 282-289.
13. Schlinkert RT, Heerdan JA, Goellner JR, Gharib H, Smith SL, Rosales RF et al. Factors that predict malignant thyroid lesions when fine-needle aspiration is «suspicious for follicular neoplasm». Mayo Clin Proc 1997; 72: 913-916.
14. Tuttle RM, Lemar H, Burch HB. Clinical features associatec with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid 1998; 8: 377-383.
15. Alonso N, Lucas A, Salinas I, Murillo J, Castella E, Sanmarti A. Enfermedad nodular tioridea y diagnóstico citolȯgico de proliferacion folicular. Caracteristicas clinicas asociadas. Endocnnologia y Nutriciȯn 1999; 46 (Supl 1): 40.
16. Russo D, Arturi F, Pontecorvi A, Filetti S. Genetic analysis in fine-needle aspiration of the thyroid: a new tool for the clinic. TEM 1999; 10: 280-285.
17. Astorga R, García-Cantón JA, Rodríguez JR, Leal A, Acosta D, Gavilán I et al. Fiabilidad de la punción aspirativa con aguja fina en el bocio nodular no tóxico. Correlación con los hallazgos quirúrgicos y punciones repetidas. Med Clin (Barc) 1985; 85: 733-736.
18. Lucas A, Llatjós M, Salinas I, Reverter J, Pizarro E, Sanmarti A. Fine-needle aspiration cytology of benign nodular thyroid disease. Value of reaspiration. Eur J Endocrinol 1995; 132: 677-680.
19. Aguilar J, Rodriguez JM, Flores B, Sola J, Bas A, Soria T et al. Value of repeated fine-needle aspiration cytology and cytologic experience on the management ot thyroid nodules. Otolaryngol Head Neck Surg 1998; 119: 121-124.
20. Erickson D, Gharib H, Li H, Heerden JA. Treatment of patients with toxic multinodular goiter. Thyroid 1998; 8: 277-282.
21. Nygaard B, Hegedüs L, Nielsen KG, Ulriksen P, Hansen JM. Long-term effect radioactive iodine en thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules. Clin Endocrinol 1999; 50: 197-202.
22. Papini E, Pacella CM, Verde G. Percutaneous ethanol injection (PEI): what is its role in the treatmenl of benign thyroid nodules? Thyroid 1995; 5: 147-150.
23. Lippi F, Ferrari C, Manetti L, Rago T, Santini F, Monzani F et al. Treatmenl of solitary autonomous thyroid nodules by percutaneous ethanol injection: results of an Italian multicenter study. J Clin Endocrinol Metab 1996; 81: 3261-3264.
24. Caraccio N, Goletti O, Lippolis PV, Casolaro A, Cavina E, Miccoli P et al. Is percutaneous ethanol injection a useful alternative for the treatment of the cold benign thyroid nodule? Five years' experience. Thyroid 1997; 7: 699-704.
25. Bennedbaek FN, Nielsen LK, Hegedus L. Effect of percutaneous ethanol injection therapy versus suppressive doses of L-thyroxine on benign solitary solid cold thyroid nodules: a randomized trial. J Clin Endocrinol Metab 1998; 83: 830-835.
26. Zingrillo M, Collura D, Ghiggi MR, Nirchio V, Trischitta V. Treatment of large cold benign thyroid nodules not eligible for surgery wth percutaneous ethanol injection. J Clin Endocrinol Metab 1998; 83: 3905-3907.
27. Bennedbaek FN, Hegedus L. Percutaneous ethanol injection therapy in benign solitary solid cold thyroid nodules: a randomized trial comparing one injection with three injections. Thyroid 1999; 9: 225-233.
28. Monzani F, Lippi F, Goletti O, Del Guerra P, Caraccio N, Lippolis PY et al. Percutaneous aspiration and ethanol sclerotherapy for thyroid cysts. J Clin Endocrinol Metab 1994; 78: 800-802.
29. Huysmans D, Hermus A, Edelbroek M, Barentsz J, Corstens F, Kloppenborg P. Radioiodine for nontoxic multinodular goiter. Thyroid 1997; 7: 235-238.
30. ICI therapy of multinodular goitre. Clin Endocrinol 1994; 41: 715-718.
31. Ridgway EC. Medical treatment of benign thyroid nodules: have we defined a benefit? Ann Intern Med 1998; 128: 403-405.
32. Ridgway EC. Clinical review 30: clinician's evaluation of a solitary thyroid nodule. J Clin Endocrinol Metab 1992; 74: 231-235.
33. Reverter JL, Lucas A, Salinas I, Audí L, Foz M, Sanmartí A. Suppressive therapy with levothyroxine for solitary thyroid nodules. Clin Endocrinol 1992; 36: 25-28.
34. La Rosa GL, Lupo L, Giuffrida D, Gullo D, Vigneri R, Belfiore A. Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the tnyroid. Ann Intern Med 1995; 122: 1-8.
35. Mainini E, Martirtelli I, Morandi G, Villa S, Stefani I, Mazzi C. Levothyroxine supressive therapy for solitary thyroid nodule. J Endocrinol Invest 1995; 18: 796-799.
36. Lima N, Knobel M, Cavaliere H, Sztejnsznajd C, Tomimori E, Medeiros-Neto G. Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters. Thyroid 1997; 7: 691-697.
37. Papini E, Petrucci L, Guglielmi R, Panunzi C, Rinaldi R, Bacci V et al. Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab 1998; 83: 780-783.
38. Zelmanovitz F, Genro S, Gross JL. Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses. J Clin Endocrinol Metab 1998; 83: 3881-3885.
39. La Rosa GL, lppolito AM, Lupo L, Cercabene G, Santonocito MG, Vignien R et al. Cold thyroid nodule reduction with L-thyroxine can be predicted by initial nodule volume and cytological characteristics. J Clin Endocrinol Metab 1996; 81: 4385-4387.
40. Tseleni-Balafouta S, Katsouyanni K, Kitsopanides J, Koutras DA. The outcome of benign thyroid nodules correlates with the findings of fine needle biopsy. Thyroidology 1991; 3: 75-78.
41. Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY. Effects on bone mass of long term treatment with thyroid hormones. J Clin Endocrinol Metab 1996; 81: 4278-4312.
42. Bauer DC, Nevitt MC, Ett nger B, Stone K. Low thyrotropin levels are not associated with bone loss in older women: a prospective study. J Clin Endocrinol Metab 1997; 82: 2931-2936.
43. López Álvarez MB, Hawkins F, Rigopoulou D, Martinez G, Jodar E, Estenoz J et al. Factores de riesgo y densidad mineral ósea en mujeres en tratamiento prolongado con evotiroxina. Med Clin (Barc) 1999; 112: 85-89.
44. Biondi B, Fazio S, Carella C, Amato G, Cittadini A, Lupoli G et al. Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. Clin Endocrinol Metab 1993; 77: 334-338.
45. Klein I, Hong C. Effects of thyroid hormone on cardiac size and myosin content of the heterotopically transplanted rat heart. J Clin Invest 1986; 77: 1694-1698.
46. Pizarro E, Lucas A, Reverter JL, Rius F, Salinas I, Sanmartí A. Nuestra experiencia en 275 casos de bocio multinodular. Aspectos clinicos y terapéuticos. Endocrinología 1993; 40: 143-147.
47. Hagag P, Strauss S, Weiss M. Role of ultrasound-guided fine-needle aspiration biopsy in evaluation of nonpalpable thyroid nodules. Thyroid 1998; 8: 989-995.